Joana Correia, Executive Director and Chief Scientific Officer presented last week at Cord Blood World Europe. Under the theme: “Umbilical cord blood supply for the development of Exo-Wound, an exosome-based product for chronic wounds” Joana talked about the technology behind Exo-Wound and the advantages and challenges of using exosomes as a therapeutic tool but also about[…]
Exogenus Therapeutics was one of the three finalist projects of the EWMA Alira Health 2nd Wound Care Innovation Symposium that took place on May 4th, at the European Wound Management Association Conference in Amsterdam. Having the opportunity to present its innovative technology to industry leaders and clinicians during this recognized international forum was part of the[…]
It was announced last week that Joana Simões Correia, the Executive Director of Exogenus Therapeutics (Exo-T) is one of the Young Transatlantic Innovation Leaders of 2017. The Young Transatlantic Innovative Leaders Initiative Fellowship is the flagship program of the Young Transatlantic Innovation Leaders Initiative (YTILI) of the U.S. Department of State and is supported in[…]
EDITAL PARA A ATRIBUIÇÃO DE BOLSA Bolsa de Doutoramento (1) Encontra-se aberto concurso para a atribuição de uma Bolsa de Doutoramento no âmbito do projeto interno: “Desenvolvimento de um medicamento biológico para tratamento de feridas da pele” da Exogenus Therapeutics, nas seguintes condições: Área Científica: Engenharia Biomédica Requisitos de admissão: Serão admitidos a concurso os[…]
It was announced today that Exogenus Therapeutics (Exo-T) is the winner of the Everis Foundation Award 2016. The award, which every year distinguishes projects from Industry, Biotechnology & Health, and Digital Economy originating from countries where the Everis Group has operations, counted in this XV edition with more than 600 applications from 10 different countries.[…]
Exogenus Therapeutics (Exo-T) is one of the selected SMEs to receive support from the European Commission under the Horizon 2020’s SME Instrument Phase 1. With the SME Instrument, the European Commission aims to support high growth, highly innovative European SMEs with global ambitions and with a mission to disrupt existing markets. This is a highly[…]
Exo-T are proud to have been chosen as one of the 6 finalists of the Everis Foundation Award 2016. Selected among 600 projects of the areas of Industry, Biotechnology & Health and Digital, Exo-T is the only Portuguese representative left in the run-up to the final, taking place in September. It has been a great[…]
Renato Cardoso is the new member of Exogenus Therapeutics’ team. Renato is graduated in Chemistry, Master in Advanced Chemistry, and a PhD in Chemistry, with specialization in Biological Chemistry by the University of Coimbra.
Watch Joana Correia’s interview on Sic Noticias Edição da Manhã talking about Exo-T! http://goo.gl/tLVSB9
Exogenus Therapeutics features in i9 magazine‘s February edition. Check out this new paper and digital publication getting a grip on innovation pulse in Portugal! http://portal.i9magazine.pt/exogenus-therapeutics-regenera…/